Around 3mil shares buy order by one on 63, page-48

AHZ is not running a corner grocery shop. They're developing world leading biotech innovations, which is hugely expensive, and marketing and further developing existing ones.

If they'd made zero progress I could understand your anger. But that is hardly the case here.

Perhaps we should save on staffing, sack all the top rate scientists and lab technicians and experts, get third rate people in, make more cost savings and see where it gets you?

But the fact is they're making significant and meaningful progress, and this is not just a question of a few paper shufflers doodling around all day.

There is pain associated with the consolidation. No question. I feel it, we all feel it. But venting your anger is not a productive response.

Let's get real. You need first class staff for this important work. AHZ is world leading. To retain first class staff capable of making progress you must pay them appropriately and give them incentives.

By comparison, what are we doing? Investing hard earned cash, watching and worrying about how rich this is going to make us. That is all. We're not at the coal face of science, we're only backing them financially. Adoption takes time. Progress is being made. This is life.

Some expectations (eg. cardiocell adoption) might be dashed to an extent, but we need to stay calm and not make ill-conceived attacks. Stage 2 and 3 clinical trials are very expensive indeed. Sometimes life throws curve balls. This is a bump in the road and necessary for funding. Let's not attack the company just because we're disappointed.

Research scientists experience disappointment all the time, making progress is an exercise in constant re-evaluation, adjustment, patience and resilience. Same with investing.

I'm expecting some of my bios to do really well in the long term.
Early on I took a call on AHZ as likely to mature a bit later than some of my other biotechs. I was right, but not all that drastically right. The others have also experienced delays (a JV fell over due to a takeover, etc etc etc); this is life.

When AHZ is like CSL, we may well look back and ask ourselves what all the fuss was about. I will be indeed happy when the SP is over $10. When it nears $100 I won't be worried about having fewer shares than I might because it's a question of being able to progress or not progress.

AHZ are in the business of saving lives and improving health and well-being and it's not an easy road. Sorry to come over all Pollanna but surely we're occupying a position of great privilege living in this country and being able to back this opportunity.

OK, after the consolidation on a personal level, it might be not as colossal to our personal finances as some had hoped. But it's still going to be very very big. Maybe it's going to be more about being just well off instead of sickeningly rich. I can live with that if it means the company can move forward.